Jellyfish Derived Compounds
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 1513
Special Issue Editors
Interests: jellyfish; microalgae; blue-biotechnology; bioactive compounds; antioxidants; anticancer; nutraceuticals; marine plants; novel foods; drug discovery; gap junction intercellular communications (GJIC)
Special Issues, Collections and Topics in MDPI journals
Interests: jellyfish bioactive products; nutraceuticals; novel foods; cell culture systems; plant molecular biology; lipid metabolism
Special Issue Information
Dear Colleagues,
The wide biodiversity of cnidarians makes them a top candidate for the development of biochemical strategies for survival (feeding and defense), development, and reproduction, including symbiosis or other relationships with microalgae and other micro- and macro-organisms. Cnidarian venomous compounds are also viewed with particular interest for their role and biological activities.
Despite the increasing attention being paid to jellyfish blooms, the biochemical, physical–chemical characterization, and bioactivity definition of jellyfish-derived compounds, supporting their possible utilization and exploitation, is still limited.
In this as yet unexplored biodiversity, jellyfish could represent a huge reservoir of new molecules for drug discovery and potentially a relatively untapped sustainable resource for biomaterials and natural compounds with a broad spectrum of applications.
This Special Issue will collect research papers and original reviews focusing on jellyfish-derived compounds that for use as pharmaceuticals, nutraceuticals, and cosmeceuticals, for biotechnological and biomedical applications, and for biomaterial development and bio-based industry.
Dr. Antonella Leone
Dr. Stefania De Domenico
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- jellyfish proteins and peptides
- bioactive compounds
- anti-cancer
- photoprotection
- jellyfish collagen
- jellyfish symbionts
- cosmetics and cosmeceuticals
- nutraceuticals
- biomaterials
- novel foods
- jellyfish associated microbiome
